Cancer Causes & Control

, Volume 6, Issue 6, pp 492–498

Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States)

  • Kathleen L. Danley
  • Jean L. Richardson
  • Leslie Bernstein
  • Bryan Langholz
  • Ronald K. Ross
Research Papers

Between 1976 and 1988 in the United States, the secular trends in age-adjusted incidence rates of prostate cancer were significantly different by racial/ethnic group (P<0.001), and increased significantly only among non-Hispanic Whites at a rate of 2.7 percent (95 percent confidence interval [CI]=2.3–3.1%) annually. While incidence rates of regional disease increased significantly (7.7 percent to 11.3 percent annually) among all racial/ethnic groups during this period, localized disease increased significantly only among non-Hispanic Whites, by 1.8 percent (CI=1.4–2.3%) annually. Prostate cancer mortality in Los Angeles County (California) remained constant among Hispanics, non-Hispanic Whites, and Asians, but increased 1.6 percent (CI=0–3.2%) annually among Blacks. While the increase in localized disease rates of non-Hispanic Whites may be due to increased detection of asymptomatic disease, this apparently has not occurred among other racial/ethnic groups in Los Angeles County. The secular increase in regional disease rates among all racial/ethnic groups without a concurrent increase in mortality (except Blacks), suggests increased accuracy of staging rather than a true increase in incidence may account for these trends. Adjusted for socioeconomic status, year and age at diagnosis, Black and Hispanic men were at significantly higher risk of being diagnosed with non-localized disease (odds ratio = 1.39 and 1.24, respectively) than were non-Hispanic Whites.

Key words

Ethnicity males prostate cancer incidence prostate cancer mortality race United States 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chiarodo A. National Cancer Institute roundtable on prostate cancer: Future research directions. Cancer Res 1991; 51: 2498–505.Google Scholar
  2. 2.
    National Cancer Institute. Cancer Statistics Review 1973–1987. Bethesda, MD (USA) Division of Cancer Prevention and Control, 1990; DHHS Pub. No. NIH 90–2789.Google Scholar
  3. 3.
    Muir CS, Nectous J, Staszewski J. The epidemiology of prostatic cancer. Geographic distribution and timetrends. Acta Oncol 1991; 30: 133–40.Google Scholar
  4. 4.
    Department de Salud. Cancer en Puerto Rico 1991. San Juan, Puerto Rico: Department de Calud, 1993.Google Scholar
  5. 5.
    Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet 1994; 243: 251–4.Google Scholar
  6. 6.
    Waterhouse J, Muir C, Correa P, Powell J. Cancer Incidence In Five Continents, Vol. III. Lyon, France: International Agency for Research on Cancer, 1976; IARC Pub. No. 15.Google Scholar
  7. 7.
    Waterhouse J, Muir C, Shanmugaratnam K, Powell J. Cancer Incidence in Five Continents, Vol, IV. Lyon, France: International Agency for Research on Cancer, 1982; IARC Sci. Pub. No. 42.Google Scholar
  8. 8.
    Muir C, Waterhouse J, Mack T, Powell J, Whelen S. Cancer Incidence In Five Continents, Vol. V. Lyon, France: International Agency for Research on Cancer, 1987; IARC Sci. Pub. No. 88.Google Scholar
  9. 9.
    Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection. JNCI 1990; 82: 1624–8.Google Scholar
  10. 10.
    Hanks GE, Myers CE, Scardino PT. Cancer of the prostate. In: De Vita VTJr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, Fourth Edition. Philadelphia, PA (USA): J.B. Lippincott Co, 1993; 1073–108.Google Scholar
  11. 11.
    Gilliland FD, Becker TM, Key CR, Samet JM. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks. Cancer 1994; 73: 2192–9.Google Scholar
  12. 12.
    Natarajan N, Murphy GP, Mettlin C. Prostate cancer in Blacks: an update from the American College of Surgeons' Pattern of Care Studies. J Surg Oncol 1989; 40: 232–6.Google Scholar
  13. 13.
    Levine MS, Arger PH, Coleman BG, Mulhern CBJr, Pollack HM, Wein AJ. Detecting lymphatic metastases from prostatic carcinoma: superiority of CT. Am J Roentgen 1981; 137: 207–11.Google Scholar
  14. 14.
    Schaffer D, Pendergrass HP. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 1976; 121: 431–4.Google Scholar
  15. 15.
    Murphy GP, Natarajan JE, Pontes JE, et al. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urology 1982; 127: 928–34.Google Scholar
  16. 16.
    Thompson IM, Rounder JB, Teague JL, Peek M, Spence CR. Impact of routine screening for adenocarcinoma of the prostate on stage distribution. J Urology 1987; 137: 424–6.Google Scholar
  17. 17.
    Garnick MB. Prostate cancer: screening, diagnosis and management. Ann Int Med 1993; 118: 804–18.Google Scholar
  18. 18.
    Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer 1992; 70: 2152–8.Google Scholar
  19. 19.
    Austin JP, Aziz H, Potters L, et al. Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol 1990; 13: 465–9.Google Scholar
  20. 20.
    Meikle AW, Smith JAJr, Epidemiology of prostate cancer. Urol Clin N Amer 1990; 17: 709–18.Google Scholar
  21. 21.
    Mack TM. Cancer Surveillance Program in Los Angeles County. Natl Cancer Inst Monogr 1977; 47: 99–101.Google Scholar
  22. 22.
    Hollingshead AB, Redlich FC. Social Class and Mental Illness. New York, NY (USA): Wiley, 1958.Google Scholar
  23. 23.
    Breslow NE, Day NE. Statistical Methods in Cancer Research: Vol. II. The Design and Analysis of Cobort Studies. Lyon, France: International Agency for Research on Cancer, 1987: IARC Sci. Pub. No. 82: 120–37.Google Scholar
  24. 24.
    Menck HR, Henderson BE, Pike MC, Mack T, Martin SP, SooHoo J. Cancer incidence in the Mexican-American JNCI 1975; 55: 531–6.Google Scholar
  25. 25.
    Sidney S, Quesenberry CPJr, Sadler MC, Guess HA, Lydick EG, Cattolica EV. Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol 1991; 134: 825–9.Google Scholar

Copyright information

© Rapid Science Publishers 1995

Authors and Affiliations

  • Kathleen L. Danley
    • 1
  • Jean L. Richardson
    • 1
  • Leslie Bernstein
    • 1
    • 2
  • Bryan Langholz
    • 1
  • Ronald K. Ross
    • 1
    • 2
  1. 1.Department of Preventive MedicineUniversity of Southern California School of MedicineLos AngelesUSA
  2. 2.Department of Preventive MedicineUSC School of MedicineLos AngelesUSA

Personalised recommendations